Pfizer has begun a study comparing its original COVID-19 vaccine with doses specially tweaked to match the omicron variant.
An advisory panel of the World Health Organization classified on Nov. 27, 2021, a worrying new COVID-19 variant first detected in South Africa as a highly transmissible virus of concern, naming it "Omicron" under its Greek letter system.
While omicron is more likely than previous variants to cause infection even in people who’ve been vaccinated, it’s not yet clear that a change to the vaccine recipe is needed.The original vaccines still offer good protection against severe illness and death. Studies in the U.S. and elsewhere have made clear that adding a booster dose strengthens that protection and improves the chances of avoiding a milder infection.
The new U.S. study is enrolling up to 1,420 healthy adults, ages 18 to 55, to test the updated omicron-based shots for use as a booster or for primary vaccinations. Researchers will examine the tweaked vaccine’s safety and how it revs up the immune system in comparison to the original shots.
Indonesia Berita Terbaru, Indonesia Berita utama
Similar News:Anda juga dapat membaca berita serupa dengan ini yang kami kumpulkan dari sumber berita lain.
Covid-19 news: Strain on health services led to extra non-covid deathsToday’s covid-19 news: · 4000 excess non-covid 19 deaths occurred in England during first year of pandemic · Acute phase of pandemic could end in 2022 with improved vaccination rates, says WHO · Israel recommends fourth vaccine dose for all adults
Baca lebih lajut »
Pfizer, BioNTech begin omicron-specific COVID-19 vaccine studyCOVID-19 vaccine-makers Pfizer and BioNTech announced Tuesday that the companies would test an omicron-specific vaccine candidate in healthy adults ages 18 to 55.
Baca lebih lajut »
Pfizer says it's starting clinical studies of an omicron-based COVID-19 vaccinePfizer and BioNTech said Tuesday they've stated clinical trials for an omicron-based COVID-19 vaccine.
Baca lebih lajut »
65% Of Skilled Nursing Facility Staff Boosted Against COVID-19Vaccination rates among residents and staff at skilled nursing facilities remain above 90%, however many have yet to receive their booster shot.
Baca lebih lajut »
Biden Administration Limits Use of Regeneron and Lilly Covid-19 Antibody DrugsThe FDA revised the authorizations for the therapies, which don’t work against the Omicron variant, to make sure doctors only use them on non-Omicron patients, and the Health and Human Services Department stopped shipments.
Baca lebih lajut »
COVID-19 Vaxmobile to visit Tarrant County areas with low vaccination ratesA 60-foot bus has been converted to a fully equipped mobile vaccine clinic that will make weekly stops in Tarrant County areas with the lowest vaccination rates.
Baca lebih lajut »